Love it ssp!

Sep 30 was a hard landing, but at least the plane didn't explode. Really looking forward to AGM and AHA, truly think we are closer than Sep 30 would indicate at that moment in time. Have a gut feeling will will learn a lot of good things about apabetalone, it's potential, and hopefully there is some "actionable" data in the short term rather than more "futures" with extended studies.

It is hard to get drugs successfully thru studies, the FDA, and to market. Hopefully apabetalone and RVX can cut it, with good FLD.

Very interested to see/hear whatever they can/will say at the late Oct AGM for information & mood, and then of course FLD at AHA.

I am more concerned about time frames, rather than "ultimate" success. Patent life, epigenetics industry lead time, finances. The stability of the pps right now is encouraging though, as well.

I am still a BIG supporter of rallying the medical/academic communities in support ("demand") of apabetalone at the grass roots level if FLD is what we hope despite the TLD miss. And also, partnering with a fully capable BP with resources, knowledge, clout, past successes to help get this across the goal line, and on to commercialization - approval, manufacturing, marketing, sales, logistics & distribution.

AGM / AHA ... tick tock 2